Save time and cost with plexWell. Contact us today!

The seqWell team is revolutionizing NGS library prep to unlock the full potential of today’s DNA sequencing instruments.

With employees located across the globe, we maintain a collaborative, flexible culture that encourages discovery, professional development, and continual improvement. Our growing team includes people with various backgrounds who share a love for science and the goal of empowering scientists by providing the best next generation sequencing technology to accelerate their research.

Building on core strengths of molecular reagent design and workflow engineering, seqWell’s product portfolio allows improvements in the scale and quality of DNA sequencing results. Our plexWell™ platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. plexWell™ has wide-ranging impact on applications from synthetic biology, targeted sequencing and single-cell analysis to low and high depth sequencing of human, plant, animal and microbial genomes.

Our mission is to change the future of NGS applications.

It’s a mission that our diverse team is committed to accomplishing. seqWell was built around the simple idea that innovative reagent-based solutions can eliminate many time- and cost-consuming elements of library prep. seqWell’s technologies will enable more research, optimize lab efficiency and maximize NGS technology. New products, technologies and challenges are on the horizon and we need your help to meet these challenges with creativity and fervor.

Interested in joining our team? Feel free to email us at [email protected]

workplace of the year award for seqWell

seqWell Awarded “Workplace of the Year”

This award recognizes companies that provide opportunities for personal and professional development. seqWell has supported their employees during this difficult year and has ensured a great work environment for all.

Don’t see your dream job listed above?

No problem! If you have a specific job position in mind, please attach your resume and send an email to [email protected]

seqWell is an Equal Opportunity Employer and Prohibits Discrimination and Harassment of Any Kind: seqWell is committed to the principle of equal employment opportunity for all employees and to providing employees with a work environment free of discrimination and harassment. All employment decisions at seqWell are based on business needs, job requirements and individual qualifications, without regard to race, color, religion or belief, national, social or ethnic origin, sex (including pregnancy), age, physical, mental or sensory disability, HIV status, sexual orientation, gender identity and/or expression, marital, civil union or domestic partnership status, past or present military service, family medical history or genetic information, family or parental status, or any other status protected by the laws or regulations in the locations where we operate. seqWell will not tolerate discrimination or harassment based on any of these characteristics.
Caught in the Act: Tracking the Emergence and Divergence of SARS-CoV-2 through Statewide Testing and SequencingUPCOMING WEBINAR

Date:  March 23, 2022
Time: 11:00am (PDT),  2:00pm (EDT), 8:00pm (CEDT)

Learning Objectives

  • Understand the utility of full-genome viral sequence analysis for public health
  • Recognize how viral load impacts the ability to detect and sequence intact SARS-CoV-2
  • Identify the similarities and differences in host responses to SARS-CoV-2 depending on strain and immunologic history


Frank A. Middleton, Ph.D.
Professor Director, SUNY Molecular Analysis CoreState University of New York (SUNY) Upstate Medical University

Joseph C. Mellor, Ph.D.
Co-founder and Chief Scientific Officer of seqWell Inc.